Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-45l2p Total loading time: 0 Render date: 2024-04-26T11:26:27.871Z Has data issue: false hasContentIssue false

Chapter 17 - Early clinical features of the parkinsonian-related dementias

Published online by Cambridge University Press:  01 December 2016

By
Maya Katz ,
Peter Pressman  and
Bradley F. Boeve
Edited by
Bruce L. Miller  and
Bradley F. Boeve
Bruce L. Miller
Affiliation:
University of California, San Francisco
Bradley F. Boeve
Affiliation:
Mayo Clinic, Minnesota
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
The Behavioral Neurology of Dementia , pp. 245 - 277
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Nath, U, Ben-Shlomo, Y, Thomson, R, Lees, A, Burn, D. Clinical features and natural history of progressive supranuclear palsy A clinical cohort study. Neurology. 2003;60(6):910–16.CrossRefGoogle ScholarPubMed
Ratnavalli, E, Brayne, C, Dawson, K, Hodges, JR. The prevalence of frontotemporal dementia. Neurology. 2002;58(11):1615–21.CrossRefGoogle ScholarPubMed
Savica, R, Grossardt, BR, Bower, JH, Ahlskog, JE, Rocca, WA. Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism. JAMA Neurology. 2013;70(7):859–66.CrossRefGoogle ScholarPubMed
Savica, R, Grossardt, BR, Bower, JH, Boeve, BF, Ahlskog, JE, Rocca, WA. Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurology. 2013;70(11):1396–402.CrossRefGoogle ScholarPubMed
Tran, HT, Chung, CH-Y, Iba, M, Zhang, B, Trojanowski, JQ, Luk, KC, et al. α-Synuclein immunotherapy blocks uptake and templated propagation of misfolded α-synuclein and neurodegeneration. Cell Reports. 2014;7(6):2054–65.CrossRefGoogle ScholarPubMed
Schneider, SA, Hardy, J, Bhatia, KP. Syndromes of neurodegeneration with brain iron accumulation (NBIA): an update on clinical presentations, histological and genetic underpinnings, and treatment considerations. Movement Disorders. 2012;27(1):42–53.CrossRefGoogle ScholarPubMed
Mak, CM, Lam, C-W. Diagnosis of Wilson’s disease: a comprehensive review. Critical Reviews in Clinical Laboratory Sciences. 2008;45(3):263–90.CrossRefGoogle ScholarPubMed
Steele, JC. Parkinsonism– dementia complex of Guam. Movement Disorders. 2005;20(S12):S99–107.CrossRefGoogle ScholarPubMed
Huang, Y, Halliday, G. Can we clinically diagnose dementia with Lewy bodies yet? Translational Neurodegeneration. 2013;2(1):4.CrossRefGoogle ScholarPubMed
McKeith, I. Dementia with Lewy bodies and Parkinson’s disease with dementia: where two worlds collide. Practical Neurology. 2007;7(6):374–82.CrossRefGoogle ScholarPubMed
McKeith, I, Dickson, D, Lowe, J, Emre, M, O’Brien, J, Feldman, H, et al. Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology. 2005;65(12):1863–72.CrossRefGoogle ScholarPubMed
Aarsland, D, Andersen, K, Larsen, JP, Lolk, A. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Archives of Neurology. 2003;60(3):387–92.CrossRefGoogle ScholarPubMed
Aarsland, D, Kvaløy, J, Andersen, K, Larsen, J, Tang, M, Lolk, A, et al. The effect of age of onset of PD on risk of dementia. Journal of Neurology. 2007;254(1):38–45.CrossRefGoogle ScholarPubMed
Emre, M, Aarsland, D, Brown, R, Burn, DJ, Duyckaerts, C, Mizuno, Y, et al. Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Movement Disorders. 2007;22(12):1689–707.CrossRefGoogle ScholarPubMed
Hughes, T, Ross, H, Musa, S, Bhattacherjee, S, Nathan, R, Mindham, R, et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease. Neurology. 2000;54(8):1596–603.Google Scholar
Brüggemann, N, Klein, C. Parkin type of early-onset Parkinson disease. Seattle (WA): University of Washington; 2013.Google ScholarPubMed
Elbaz, A, Bower, JH, Peterson, BJ, Maraganore, DM, McDonnell, SK, Ahlskog, JE, et al. Survival study of Parkinson disease in Olmsted county, Minnesota. Archives of Neurology. 2003;60(1):91–6.CrossRefGoogle Scholar
Morgan, JC, Currie, LJ, Harrison, MB, Bennett, JP, Trugman, JM, Wooten, GF. Mortality in levodopa-treated Parkinson’s disease. Parkinson’s Disease. Article ID 426976, 8 pages, 2014. doi:10.1155/2014/426976.CrossRefGoogle ScholarPubMed
Puschmann, A. Monogenic Parkinson’s disease and parkinsonism: clinical phenotypes and frequencies of known mutations. Parkinsonism & Related Disorders. 2013;19(4):407–15.CrossRefGoogle Scholar
Wickremaratchi, M, Perera, D, O’loghlen, C, Sastry, D, Morgan, E, Jones, A, et al. Prevalence and age of onset of Parkinson’s disease in Cardiff: a community based cross sectional study and meta-analysis. Journal of Neurology, Neurosurgery & Psychiatry. 2009;80(7):805–7.CrossRefGoogle ScholarPubMed
Geser, F, Wenning, GK, Poewe, W, McKeith, I. How to diagnose dementia with Lewy bodies: state of the art. Movement Disorders. 2005;20(S12):S11–S20.CrossRefGoogle ScholarPubMed
Han, D, Wang, Q, Gao, Z, Chen, T, Wang, Z. Clinical features of dementia with Lewy bodies in 35 Chinese patients. Translational Neurodegeneration. 2014;3(1):1.Google Scholar
Jellinger, KA, Wenning, GK, Seppi, K. Predictors of survival in dementia with Lewy bodies and Parkinson dementia. Neuro-degenerative Diseases. 2006;4(6):428–30.CrossRefGoogle ScholarPubMed
Olichney, JM, Galasko, D, Salmon, D, Hofstetter, C, Hansen, L, Katzman, R, et al. Cognitive decline is faster in Lewy body variant than in Alzheimer’s disease. Neurology. 1998;51(2):351–7.Google ScholarPubMed
Tanner, CM, Ottman, R, Goldman, SM, Ellenberg, J, Chan, P, Mayeux, R, et al. Parkinson disease in twins: an etiologic study. Journal of the American Medical Association. 1999;281(4):341–6.CrossRefGoogle ScholarPubMed
Klatka, LA, Louis, ED, Schiffer, RB. Psychiatric features in diffuse Lewy body disease A clinicopathologic study using Alzheimer’s disease and Parkinson’s disease comparison groups. Neurology. 1996;47(5):1148–52.CrossRefGoogle ScholarPubMed
Williams, MM, Xiong, C, Morris, JC, Galvin, JE. Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease. Neurology. 2006;67(11):1935–41.CrossRefGoogle ScholarPubMed
Apaydin, H, Ahlskog, JE, Parisi, JE, Boeve, BF, Dickson, DW. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Archives of Neurology. 2002;59(1):102–12.CrossRefGoogle ScholarPubMed
Dickson, DW. Dementia with Lewy bodies: neuropathology. Journal of Geriatric Psychiatry and Neurology. 2002;15(4):210–16.CrossRefGoogle ScholarPubMed
Tsuboi, Y, Dickson, DW. Dementia with Lewy bodies and Parkinson’s disease with dementia: are they different? Parkinsonism & Related Disorders. 2005;11:S47–51.CrossRefGoogle ScholarPubMed
McKeith, I, Dickson, D, Lowe, J, Emre, M, O’Brien, J, Feldman, H. Dementia with Lewy bodies: diagnosis and management: third report of the DLB Consortium. Neurology. 2005;65(12):1863–72.CrossRefGoogle ScholarPubMed
Boeve, B, Silber, M, Saper, C, Ferman, T, Dickson, D, Parisi, J, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. 2007;130(11):2770–88.CrossRefGoogle ScholarPubMed
Ferman, T, Boeve, B, Smith, G, Lin, S-C, Silber, M, Pedraza, O, et al. Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology. 2011;77(9):875–82.CrossRefGoogle ScholarPubMed
Ferman, TJ, Smith, GE, Boeve, BF, Graff-Radford, NR, Lucas, JA, Knopman, DS, et al. Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer’s disease. The Clinical Neuropsychologist. 2006;20(4):623–36.CrossRefGoogle ScholarPubMed
Simard, M, van Reekum, R, Cohen, T. A review of the cognitive and behavioral symptoms in dementia with Lewy bodies. The Journal of Neuropsychiatry and Clinical Neurosciences. 2000;12:425–50.CrossRefGoogle ScholarPubMed
Petersen, RC. Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine. 2004;256(3):183–94.Google Scholar
Ferman, TJ, Smith, GE, Kantarci, K, Boeve, BF, Pankratz, VS, Dickson, DW, et al. Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies. Neurology. 2013;81:2032–8.CrossRefGoogle Scholar
Donaghy, PC, McKeith, IG. The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis. Alzheimer’s Research & Therapy. 2014;6(4):46.CrossRefGoogle ScholarPubMed
Ballard, C, Aarsland, D, Francis, P, Corbett, A. Neuropsychiatric symptoms in patients with dementias associated with cortical Lewy bodies: pathophysiology, clinical features, and pharmacological management. Drugs & Aging. 2013;30(8):603–11.CrossRefGoogle ScholarPubMed
Stinton, C, McKeith, I, Taylor, J-P, Lafortune, L, Mioshi, E, Mak, E, et al. Pharmacological management of Lewy body dementia: a systematic review and meta-analysis. American Journal of Psychiatry. 2015;172(8):731–42.CrossRefGoogle ScholarPubMed
McKeith, I, Del Ser, T, Spano, P, Emre, M, Wesnes, K, Anand, R, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. The Lancet. 2000;356(9247):2031–6.CrossRefGoogle ScholarPubMed
Weintraub, D, Hurtig, HI. Presentation and management of psychosis in Parkinson’s disease and dementia with Lewy bodies. The American Journal of Psychiatry. 2007;164(10):1491–8.CrossRefGoogle ScholarPubMed
Aarsland, D, Ballard, C, Larsen, JP, McKeith, I. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson’s disease with and without dementia. International Journal of Geriatric Psychiatry. 2001;16(5):528–36.CrossRefGoogle ScholarPubMed
Marantz, AG, Verghese, J. Capgras' syndrome in dementia with Lewy bodies. Journal of Geriatric Psychiatry and Neurology. 2002;15(4):239–41.CrossRefGoogle Scholar
Chiba, Y, Fujishiro, H, Ota, K, Kasanuki, K, Arai, H, Hirayasu, Y, et al. Clinical profiles of dementia with Lewy bodies with and without Alzheimer’s disease‐like hypometabolism. International Journal of Geriatric Psychiatry. 2014.CrossRefGoogle ScholarPubMed
Arnulf, I, Bonnet, A-M, Damier, P, Bejjani, B-P, Seilhean, D, Derenne, J-P, et al. Hallucinations, REM sleep, and Parkinson’s disease. A medical hypothesis. Neurology. 2000;55(2):281–8.Google Scholar
Boeve, B, Silber, M, Parisi, J, Dickson, D, Ferman, T, Petersen, R. Neuropathologic findings in patients with REM sleep behavior disorder and a neurodegenerative disorder. Neurology. 2001;56:A299.Google Scholar
Boeve, BF, Silber, MH, Ferman, TJ, Parisi, JE, Dickson, DW, Smith, GE, et al. REM sleep behavior disorder in Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy. In Mental and Behavioral Dysfunction in Movement Disorders, ed. Bédard, M-A, Agid, Y, Chouinard, S, Fahn, S, Korczyn, AD, Lespérance, P. New York: Springer; 2003. pp. 383–97.CrossRefGoogle ScholarPubMed
Perry, E, Kerwin, J, Perry, R, Blessed, G, Fairbairn, A. Visual hallucinations and the cholinergic system in dementia. Journal of Neurology, Neurosurgery, and Psychiatry. 1990;53(1):88.Google Scholar
Auning, E, Rongve, A, Fladby, T, Booij, J, Hortobágyi, T, Siepel, FJ, et al. Early and presenting symptoms of dementia with lewy bodies. Dementia and Geriatric Cognitive Disorders. 2010;32(3):202–8.CrossRefGoogle ScholarPubMed
Tiraboschi, P, Salmon, DP, Hansen, LA, Hofstetter, RC, Thal, LJ, Corey-Bloom, J. What best differentiates Lewy body from Alzheimer’s disease in early-stage dementia? Brain. 2006;129(3):729–35.CrossRefGoogle ScholarPubMed
Yamamoto, R, Iseki, E, Marui, W, Togo, T, Katsuse, O, Kato, M, et al. Non‐uniformity in the regional pattern of Lewy pathology in brains of dementia with Lewy bodies. Neuropathology. 2005;25(3):188–94.3.0.CO;2-5>CrossRefGoogle ScholarPubMed
Del Ser, T, McKeith, I, Anand, R, Cicin‐Sain, A, Ferrara, R, Spiegel, R. Dementia with Lewy bodies: findings from an international multicentre study. International Journal of Geriatric Psychiatry. 2000;15(11):1034–45.Google Scholar
Tiraboschi, P, Guerra, UP. How to distinguish dementia with Lewy bodies from Alzheimer disease? Drugs. 2010;2:3.CrossRefGoogle ScholarPubMed
Tschampa, H, Neumann, M, Zerr, I, Henkel, K, Schröter, A, Schulz-Schaeffer, W, et al. Patients with Alzheimer’s disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. Journal of Neurology, Neurosurgery & Psychiatry. 2001;71(1):33–9.CrossRefGoogle ScholarPubMed
Molloy, S, McKeith, I, O’Brien, J, Burn, D. The role of levodopa in the management of dementia with Lewy bodies. Journal of Neurology, Neurosurgery & Psychiatry. 2005;76(9):1200–3.CrossRefGoogle ScholarPubMed
Boeve, BF, Silber, MH, Ferman, TJ, Lucas, JA, Parisi, JE. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Movement Disorders. 2001;16(4):622–30.CrossRefGoogle ScholarPubMed
Boeve, BF, Silber, MH, Ferman, TJ. Current management of sleep disturbances in dementia. Current Neurology and Neuroscience Reports. 2002;2(2):169–77.CrossRefGoogle ScholarPubMed
Deschenes, CL, McCurry, SM. Current treatments for sleep disturbances in individuals with dementia. Current Psychiatry Reports. 2009;11(1):20–6.CrossRefGoogle ScholarPubMed
Iranzo, A, Tolosa, E, Gelpi, E, Molinuevo, JL, Valldeoriola, F, Serradell, M, et al. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. The Lancet Neurology. 2013;12(5):443–53.CrossRefGoogle ScholarPubMed
Terzaghi, M, Sinforiani, E, Zucchella, C, Zambrelli, E, Pasotti, C, Rustioni, V, et al. Cognitive performance in REM sleep behaviour disorder: a possible early marker of neurodegenerative disease? Sleep Medicine. 2008;9(4):343–51.CrossRefGoogle ScholarPubMed
Lessig, S, Ubhi, K, Galasko, D, Adame, A, Pham, E, Remidios, K, et al. Reduced hypocretin (orexin) levels in dementia with Lewy bodies. Neuroreport. 2010;21(11):756.CrossRefGoogle ScholarPubMed
Akaogi, Y, Asahina, M, Yamanaka, Y, Koyama, Y, Hattori, T. Sudomotor, skin vasomotor, and cardiovascular reflexes in 3 clinical forms of Lewy body disease. Neurology. 2009;73(1):59–65.CrossRefGoogle ScholarPubMed
Ballard, C, Shaw, F, McKeith, I, Kenny, R. High prevalence of neurovascular instability in neurodegenerative dementias. Neurology. 1998;51(6):1760–2.CrossRefGoogle ScholarPubMed
Hishikawa, N, Hashizume, Y, Yoshida, M, Sobue, G. Clinical and neuropathological correlates of Lewy body disease. Acta Neuropathologica. 2003;105(4):341–50.CrossRefGoogle ScholarPubMed
Thaisetthawatkul, P, Boeve, B, Benarroch, E, Sandroni, P, Ferman, T, Petersen, R, et al. Autonomic dysfunction in dementia with Lewy bodies. Neurology. 2004;62(10):1804–9.Google ScholarPubMed
Pakiam, A, Bergeron, C, Lang, AE. Diffuse Lewy body disease presenting as multiple system atrophy. The Canadian Journal of Neurological Sciences. 1999;26(2):127–31.CrossRefGoogle ScholarPubMed
Hawkes, C, Del Tredici, K, Braak, H. Parkinson’s disease: a dual‐hit hypothesis. Neuropathology and Applied Neurobiology. 2007;33(6):599–614.CrossRefGoogle ScholarPubMed
Jain, S, Goldstein, DS. Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis. Neurobiology of Disease. 2012;46(3):572–80.CrossRefGoogle ScholarPubMed
Oka, H, Morita, M, Onouchi, K, Yoshioka, M, Mochio, S, Inoue, K. Cardiovascular autonomic dysfunction in dementia with Lewy bodies and Parkinson’s disease. Journal of the Neurological Sciences. 2007;254(1):72–7.CrossRefGoogle ScholarPubMed
Walker, Z, Stevens, T. Dementia with Lewy bodies: clinical characteristics and diagnostic criteria. Journal of Geriatric Psychiatry and Neurology. 2002;15(4):188–94.CrossRefGoogle Scholar
Wilson, RS, Yu, L, Schneider, JA, Arnold, SE, Buchman, AS, Bennett, DA. Lewy bodies and olfactory dysfunction in old age. Chemical Senses. 2011:bjq139.CrossRefGoogle ScholarPubMed
Maurage, CA, Ruchoux, MM, De Vos, R, Surguchov, A, Destee, A. Retinal involvement in dementia with Lewy bodies: a clue to hallucinations? Annals of Neurology. 2003;54(4):542–7.CrossRefGoogle ScholarPubMed
Armstrong, RA. Visual signs and symptoms of dementia with Lewy bodies. Clinical and Experimental Optometry. 2012;95(6):621–30.CrossRefGoogle ScholarPubMed
Postuma, RB, Gagnon, JF, Vendette, M, Desjardins, C, Montplaisir, JY. Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Annals of Neurology. 2011;69(5):811–18.CrossRefGoogle ScholarPubMed
Brooks, DJ. Diagnosis and management of atypical Parkinsonian syndromes. Journal of Neurology, Neurosurgery & Psychiatry. 2002;72(suppl 1):i10–6.CrossRefGoogle ScholarPubMed
Mosimann, UP, Müri, RM, Burn, DJ, Felblinger, J, O'Brien, JT, McKeith, IG. Saccadic eye movement changes in Parkinson’s disease dementia and dementia with Lewy bodies. Brain. 2005;128(6):1267–76.CrossRefGoogle ScholarPubMed
Ferman, T, Smith, G, Boeve, B, Ivnik, R, Petersen, R, Knopman, D, et al. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology. 2004;62(2):181–7.CrossRefGoogle ScholarPubMed
Walker, M, Ayre, G, Cummings, J, Wesnes, K, McKeith, I, O’Brien, J, et al. Quantifying fluctuation in dementia with Lewy bodies, Alzheimer’s disease, and vascular dementia. Neurology. 2000;54(8):1616–25.Google Scholar
Walker, M, Ayre, G, Perry, E, Wesnes, K, McKeith, I, Tovee, M, et al. Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders. 1999;11(6):327–35.CrossRefGoogle ScholarPubMed
Walker, M, Ballard, C, Ayre, G, Wesnes, K, Cummings, J, McKeith, I, et al. The clinician assessment of fluctuation and the One-Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. The British Journal of Psychiatry. 2000;177(3):252–6.CrossRefGoogle ScholarPubMed
Hughes, AJ, Daniel, SE, Kilford, L, Lees, AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. Journal of Neurology, Neurosurgery & Psychiatry. 1992;55(3):181–4.CrossRefGoogle ScholarPubMed
Cools, R. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson’s disease. Neuroscience & Biobehavioral Reviews. 2006;30(1):1–23.CrossRefGoogle ScholarPubMed
Cools, R, Barker, RA, Sahakian, BJ, Robbins, TW. L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson’s disease. Neuropsychologia. 2003;41(11):1431–41.CrossRefGoogle ScholarPubMed
Caviness, JN, Driver‐Dunckley, E, Connor, DJ, Sabbagh, MN, Hentz, JG, Noble, B, et al. Defining mild cognitive impairment in Parkinson’s disease. Movement Disorders. 2007;22(9):1272–7.CrossRefGoogle ScholarPubMed
Litvan, I, Aarsland, D, Adler, CH, Goldman, JG, Kulisevsky, J, Mollenhauer, B, et al. MDS task force on mild cognitive impairment in Parkinson’s disease: Critical review of PD‐MCI. Movement Disorders. 2011;26(10):1814–24.Google ScholarPubMed
Litvan, I, Goldman, JG, Tröster, AI, Schmand, BA, Weintraub, D, Petersen, RC, et al. Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Movement Disorders. 2012;27(3):349–56.CrossRefGoogle ScholarPubMed
Marras, C, Armstrong, MJ, Meaney, CA, Fox, S, Rothberg, B, Reginold, W, et al. Measuring mild cognitive impairment in patients with Parkinson’s disease. Movement Disorders. 2013;28(5):626–33.CrossRefGoogle ScholarPubMed
Broeders, M, De Bie, R, Velseboer, D, Speelman, J, Muslimovic, D, Schmand, B. Evolution of mild cognitive impairment in Parkinson disease. Neurology. 2013;81(4):346–52.CrossRefGoogle ScholarPubMed
Pfeiffer, HCV, Løkkegaard, A, Zoetmulder, M, Friberg, L, Werdelin, L. Cognitive impairment in early‐stage non‐demented Parkinson’s disease patients. Acta Neurologica Scandinavica. 2014;129(5):307–18.CrossRefGoogle ScholarPubMed
Reijnders, JS, Ehrt, U, Weber, WE, Aarsland, D, Leentjens, AF. A systematic review of prevalence studies of depression in Parkinson’s disease. Movement Disorders. 2008;23(2):183–9.CrossRefGoogle ScholarPubMed
Kostić, VS, Pekmezović, T, Tomić, A, Ječmenica-Lukić, M, Stojković, T, Špica, V, et al. Suicide and suicidal ideation in Parkinson’s disease. Journal of the Neurological Sciences. 2010;289(1):40–3.CrossRefGoogle ScholarPubMed
Strowd, RE, Cartwright, MS, Okun, MS, Haq, I, Siddiqui, MS. Pseudobulbar affect: prevalence and quality of life impact in movement disorders. Journal of Neurology. 2010;257(8):1382–7.CrossRefGoogle ScholarPubMed
Santamaria, J, Tolosa, E, Valles, A. Parkinson’s disease with depression. A possible subgroup of idiopathic parkinsonism. Neurology. 1986;36(8):1130.CrossRefGoogle ScholarPubMed
de la Riva, P, Smith, K, Xie, SX, Weintraub, D. Course of psychiatric symptoms and global cognition in early Parkinson disease. Neurology. 2014;83(12):1096–103.CrossRefGoogle ScholarPubMed
Fénelon, G, Mahieux, F, Huon, R, Ziégler, M. Hallucinations in Parkinson’s disease. Prevalence, phenomenology and risk factors. Brain: A Journal of Neurology. 2000;123(4):733–45.Google ScholarPubMed
Sternberg, EJ, Alcalay, RN, Levy, OA, Louis, ED. Postural and intention tremors: a detailed clinical study of essential tremor vs. Parkinson’s disease. Frontiers in Neurology. 2013;4.CrossRefGoogle ScholarPubMed
Jankovic, J, Schwartz, KS, Ondo, W. Re-emergent tremor of Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry. 1999;67(5):646–50.CrossRefGoogle ScholarPubMed
Gelb, DJ, Oliver, E, Gilman, S. Diagnostic criteria for Parkinson disease. Archives of Neurology. 1999;56(1):33–9.CrossRefGoogle ScholarPubMed
Galna, B, Lord, S, Burn, DJ, Rochester, L. Progression of gait dysfunction in incident Parkinson’s disease: Impact of medication and phenotype. Movement Disorders. 2015;30(3):359–67.CrossRefGoogle ScholarPubMed
Morishita, T, Rahman, M, Foote, KD, Fargen, KM, IV Jacobson, CE, Fernandez, HH, et al. DBS candidates that fall short on a levodopa challenge test: alternative and important indications. The Neurologist. 2011;17(5):263.CrossRefGoogle ScholarPubMed
Jankovic, J. Motor fluctuations and dyskinesias in Parkinson’s disease: clinical manifestations. Movement Disorders. 2005;20(S11):S11–S6.CrossRefGoogle ScholarPubMed
Doherty, KM, van de Warrenburg, BP, Peralta, MC, Silveira-Moriyama, L, Azulay, J-P, Gershanik, OS, et al. Postural deformities in Parkinson’s disease. The Lancet Neurology. 2011;10(6):538–49.CrossRefGoogle ScholarPubMed
Riley, D, Lang, A, Blair, R, Birnbaum, A, Reid, B. Frozen shoulder and other shoulder disturbances in Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry. 1989;52(1):63–6.CrossRefGoogle ScholarPubMed
Barbeau, A. Diagnostic problems in Parkinson’s disease. Clinical Neurology and Neurosurgery. 1984;86(3):164–71.CrossRefGoogle ScholarPubMed
Gjerstad, M, Boeve, B, Wentzel-Larsen, T, Aarsland, D, Larsen, J. Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson’s disease over time. Journal of Neurology, Neurosurgery & Psychiatry. 2008;79(4):387–91.Google ScholarPubMed
Jahan, I, Hauser, RA, Sullivan, KL, Miller, A, Zesiewicz, TA. Sleep disorders in Parkinson’s disease. Neuropsychiatric Disease and Treatment. 2009;5:535.CrossRefGoogle ScholarPubMed
Fronczek, R, Overeem, S, Lee, SY, Hegeman, IM, Van Pelt, J, Van Duinen, SG, et al. Hypocretin (orexin) loss in Parkinson’s disease. Brain: A Journal of Neurology. 2007;130(6):1577–85.CrossRefGoogle ScholarPubMed
Thannickal, TC, Lai, Y-Y, Siegel, JM. Hypocretin (orexin) cell loss in Parkinson’s disease. Brain. 2007;130(6):1586–95.CrossRefGoogle ScholarPubMed
Boeve, BF, Silber, MH, Ferman, TJ. REM sleep behavior disorder in Parkinson’s disease and dementia with Lewy bodies. Journal of Geriatric Psychiatry and Neurology. 2004;17(3):146–57.CrossRefGoogle ScholarPubMed
Claassen, DO, Kutscher, SJ. Sleep disturbances in Parkinson’s disease patients and management options. Nature and Science of Sleep. 2011;3:125.CrossRefGoogle ScholarPubMed
Peeraully, T, Tan, E-K. Linking restless legs syndrome with Parkinson’s disease: clinical, imaging and genetic evidence. Translational Neurodegeneration. 2012;1(6).CrossRefGoogle ScholarPubMed
Boeve, B, Dickson, D, Olson, E, Shepard, J, Silber, M, Ferman, T, et al. Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease. Sleep Medicine. 2007;8(1):60–4.CrossRefGoogle ScholarPubMed
Boeve, BF, Saper, CB. REM sleep behavior disorder A possible early marker for synucleinopathies. Neurology. 2006;66(6):796–7.CrossRefGoogle Scholar
Livia Fantini, M, Gagnon, JF, Petit, D, Rompré, S, Décary, A, Carrier, J, et al. Slowing of electroencephalogram in rapid eye movement sleep behavior disorder. Annals of Neurology. 2003;53(6):774–80.CrossRefGoogle ScholarPubMed
Massicotte‐Marquez, J, Carrier, J, Décary, A, Mathieu, A, Vendette, M, Petit, D, et al. Slow‐wave sleep and delta power in rapid eye movement sleep behavior disorder. Annals of Neurology. 2005;57(2):277–82.CrossRefGoogle ScholarPubMed
Eisensehr, I, Linke, R, Noachtar, S, Schwarz, J, Gildehaus, F, Tatsch, K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson’s disease and controls. Brain: A Journal of Neurology. 2000;123(6):1155–60.Google Scholar
Johannes Schwarz, M, Noachtar, S. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson’s disease, and controls. Sleep. 2003;26(5):507.CrossRefGoogle ScholarPubMed
Mazza, S, Soucy, J, Gravel, P, Michaud, M, Postuma, R, Massicotte-Marquez, J, et al. Assessing whole brain perfusion changes in patients with REM sleep behavior disorder. Neurology. 2006;67(9):1618–22.Google Scholar
Caselli, RJ, Chen, K, Bandy, D, Smilovici, O, Boeve, BF, Osborne, D, et al. A preliminary fluorodeoxyglucose positron emission tomography study in healthy adults reporting dream-enactment behavior. 2006;29(7):927.CrossRefGoogle ScholarPubMed
Ferini–Strambi, L, Di Gioia, M, Castronovo, V, Oldani, A, Zucconi, M, Cappa, S. Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD) Does the idiopathic form of RBD really exist? Neurology. 2004;62(1):41–5.Google ScholarPubMed
Stiasny-Kolster, K, Doerr, Y, Möller, J, Höffken, H, Behr, T, Oertel, W, et al. Combination of ‘idiopathic’ REM sleep behaviour disorder and olfactory dysfunction as possible indicator for α-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain. 2005;128(1):126–37.CrossRefGoogle ScholarPubMed
Ferini-Strambi, L, Oldani, A, Zucconi, M, Smirne, S. Cardiac autonomic activity during wakefulness and sleep in REM sleep behavior disorder. Sleep. 1996;19(5):367–9.CrossRefGoogle ScholarPubMed
Postuma, RB, Lang, AE, Massicotte-Marquez, J, Montplaisir, J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology. 2006;66(6):845–51.CrossRefGoogle ScholarPubMed
Abbott, R, Ross, G, White, L, Tanner, C, Masaki, K, Nelson, J, et al. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology. 2005;65(9):1442–6.CrossRefGoogle ScholarPubMed
Marrinan, S, Emmanuel, AV, Burn, DJ. Delayed gastric emptying in Parkinson’s disease. Movement Disorders. 2014;29(1):23–32.CrossRefGoogle ScholarPubMed
Pellicano, C, Benincasa, D, Pisani, V, Buttarelli, FR, Giovannelli, M, Pontieri, FE. Prodromal non-motor symptoms of Parkinson’s disease. Neuropsychiatric Disease and Treatment. 2007;3(1):145.CrossRefGoogle ScholarPubMed
Bayulkem, K, Lopez, G. Nonmotor fluctuations in Parkinson’s disease: clinical spectrum and classification. Journal of the Neurological Sciences. 2010;289(1):89–92.CrossRefGoogle ScholarPubMed
Braak, H, Del Tredici, K, Rüb, U, de Vos, RA, Steur, ENJ, Braak, E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiology of Aging. 2003;24(2):197–211.CrossRefGoogle ScholarPubMed
Braak, H, Ghebremedhin, E, Rüb, U, Bratzke, H, Del Tredici, K. Stages in the development of Parkinson’s disease-related pathology. Cell and Tissue Research. 2004;318(1):121–34.CrossRefGoogle Scholar
Donadio, V, Incensi, A, Leta, V, Giannoccaro, MP, Scaglione, C, Martinelli, P, et al. Skin nerve α-synuclein deposits: A biomarker for idiopathic Parkinson’s disease. Neurology. 2014;82(15):1362–9.CrossRefGoogle ScholarPubMed
Espay, AJ, LeWitt, PA, Kaufmann, H. Norepinephrine deficiency in Parkinson’s disease: The case for noradrenergic enhancement. Movement Disorders. 2014;29(14):1710–19.CrossRefGoogle ScholarPubMed
Wang, N, Gibbons, CH, Lafo, J, Freeman, R. α-Synuclein in cutaneous autonomic nerves. Neurology. 2013;81(18):1604–10.CrossRefGoogle ScholarPubMed
Xiao, Q, Chen, S, Le, W. Hyposmia: a possible biomarker of Parkinson’s disease. Neuroscience Bulletin. 2014;30(1):134–40.CrossRefGoogle ScholarPubMed
Goldstein, DS, Holmes, C, Bentho, O, Sato, T, Moak, J, Sharabi, Y, et al. Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy. Parkinsonism & Related Disorders. 2008;14(8):600–7.CrossRefGoogle ScholarPubMed
Cecchini, MP, Osculati, F, Ottaviani, S, Boschi, F, Fasano, A, Tinazzi, M. Taste performance in Parkinson’s disease. Journal of Neural Transmission. 2014;121(2):119–22.CrossRefGoogle ScholarPubMed
Shah, M, Deeb, J, Fernando, M, Noyce, A, Visentin, E, Findley, LJ, et al. Abnormality of taste and smell in Parkinson’s disease. Parkinsonism & Related Disorders. 2009;15(3):232–7.CrossRefGoogle ScholarPubMed
Ford, B. Pain in Parkinson’s disease. Movement Disorders. 2010;25(S1):S98–103.CrossRefGoogle ScholarPubMed
Nolano, M, Provitera, V, Lanzillo, B, Santoro, L. Neuropathy in idiopathic Parkinson disease: an iatrogenic problem? Annals of Neurology. 2011;69(2):427–8.Google ScholarPubMed
Armstrong, RA. Visual symptoms in Parkinson’s disease. Parkinson’s Disease. Epub: vol. 2011, Article ID 908306, 9 pages, 2011. doi:10.4061/2011/908306.CrossRefGoogle Scholar
Lepore, FE. Parkinson’s disease and diplopia. Neuro-Ophthalmology. 2006;30(2–3):37–40.Google Scholar
Nowacka, B, Lubiński, W, Honczarenko, K, Potemkowski, A, Safranow, K. Ophthalmological features of Parkinson’s disease. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2014;20:2243.CrossRefGoogle ScholarPubMed
Pieri, V, Diederich, N, Raman, R, Goetz, C. Decreased color discrimination and contrast sensitivity in Parkinson’s disease. Journal of the Neurological Sciences. 2000;172(1):7–11.CrossRefGoogle ScholarPubMed
Pinkhardt, EH, Kassubek, J. Ocular motor abnormalities in Parkinsonian syndromes. Parkinsonism & Related Disorders. 2011;17(4):223–30.CrossRefGoogle ScholarPubMed
Almer, Z, Klein, KS, Marsh, L, Gerstenhaber, M, Repka, MX. Ocular motor and sensory function in Parkinson’s disease. Ophthalmology. 2012;119(1):178–82.CrossRefGoogle ScholarPubMed
Abe, N, Fujii, T, Hirayama, K, Takeda, A, Hosokai, Y, Ishioka, T, et al. Do Parkinsonian patients have trouble telling lies? The neurobiological basis of deceptive behaviour. Brain: A Journal of Neurology. 2009;132(5):1386–95.CrossRefGoogle ScholarPubMed
Santangelo, G, Vitale, C, Trojano, L, Errico, D, Amboni, M, Barbarulo, AM, et al. Neuropsychological correlates of theory of mind in patients with early Parkinson’s disease. Movement Disorders. 2012;27(1):98–105.CrossRefGoogle ScholarPubMed
Thaler, A, Posen, J, Giladi, N, Manor, Y, Mayanz, C, Mirelman, A, et al. Appreciation of humor is decreased among patients with Parkinson’s disease. Parkinsonism & Related Disorders. 2012;18(2):144–8.CrossRefGoogle ScholarPubMed
Hillier, A, Beversdorf, D, Raymer, A, Williamson, D, Heilman, K. Abnormal emotional word ratings in Parkinson’s disease. Neurocase. 2007;13(2):81–5.CrossRefGoogle ScholarPubMed
Wieser, MJ, Mühlberger, A, Alpers, GW, Macht, M, Ellgring, H, Pauli, P. Emotion processing in Parkinson’s disease: dissociation between early neuronal processing and explicit ratings. Clinical Neurophysiology. 2006;117(1):94–102.CrossRefGoogle ScholarPubMed
Gray, HM, Tickle-Degnen, L. A meta-analysis of performance on emotion recognition tasks in Parkinson’s disease. Neuropsychology. 2010;24(2):176.CrossRefGoogle ScholarPubMed
Steele, JC, Richardson, JC, Olszewski, J. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Archives of Neurology. 1964;10(4):333–59.CrossRefGoogle ScholarPubMed
De Bruin, V, Lees, A. Subcortical neurofibrillary degeneration presenting as Steele‐Richardson‐Olszewski and other related syndromes: A review of 90 pathologically verified cases. Movement Disorders. 1994;9(4):381–9.CrossRefGoogle ScholarPubMed
Schrag, A, Ben-Shlomo, Y, Quinn, N. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. The Lancet. 1999;354(9192):1771–5.CrossRefGoogle ScholarPubMed
Williams, DR, de Silva, R, Paviour, DC, Pittman, A, Watt, HC, Kilford, L, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP-parkinsonism. Brain: A Journal of Neurology. 2005;128(6):1247–58.CrossRefGoogle ScholarPubMed
Chiu, WZ, Kaat, LD, Seelaar, H, Rosso, SM, Boon, AJ, Kamphorst, W, et al. Survival in progressive supranuclear palsy and frontotemporal dementia. Journal of Neurology, Neurosurgery & Psychiatry. 2010;81(4):441–5.CrossRefGoogle ScholarPubMed
Diroma, C, Dell’Aquila, C, Fraddosio, A, Lamberti, S, Mastronardi, R, Russo, I, et al. Natural history and clinical features of progressive supranuclear palsy: a clinical study. Neurological Sciences. 2003;24(3):176–7.CrossRefGoogle ScholarPubMed
Litvan, I, Agid, Y, Calne, D, Campbell, G, Dubois, B, Duvoisin, R, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Report of the NINDS-SPSP International Workshop. Neurology. 1996;47(1):1–9.Google ScholarPubMed
O’Sullivan, S, Massey, L, Williams, D, Silveira-Moriyama, L, Kempster, P, Holton, J, et al. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain: A Journal of Neurology. 2008;131(5):1362–72.CrossRefGoogle ScholarPubMed
Williams, DR, Lees, AJ. What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy‐parkinsonism (PSP‐P)? Movement Disorders. 2010;25(3):357–62.CrossRefGoogle ScholarPubMed
Litvan, I, Mangone, C, McKee, A, Verny, M, Parsa, A, Jellinger, K, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. Journal of Neurology, Neurosurgery & Psychiatry. 1996;60(6):615–20.CrossRefGoogle ScholarPubMed
Respondek, G, Roeber, S, Kretzschmar, H, Troakes, C, Al‐Sarraj, S, Gelpi, E, et al. Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy. Movement Disorders. 2013;28(4):504–9.CrossRefGoogle ScholarPubMed
Wenning, GK, Litvan, I, Tolosa, E. Milestones in atypical and secondary parkinsonisms. Movement Disorders. 2011;26(6):1083–95.CrossRefGoogle ScholarPubMed
Williams, DR, Lees, AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. The Lancet Neurology. 2009;8(3):270–9.CrossRefGoogle ScholarPubMed
Josephs, K, Boeve, B, Duffy, J, Smith, G, Knopman, D, Parisi, J, et al. Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase. 2005;11(4):283–96.CrossRefGoogle ScholarPubMed
Josephs, KA, Duffy, JR, Strand, EA, Whitwell, JL, Layton, KF, Parisi, JE, et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain: A Journal of Neurology. 2006;129(6):1385–98.CrossRefGoogle ScholarPubMed
Bak, T, Crawford, L, Hearn, V, Mathuranath, P, Hodges, JR. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase. 2005;11(4):268–73.CrossRefGoogle ScholarPubMed
Dubois, B, Pillon, B, Legault, F, Agid, Y, Lhermitte, F. Slowing of cognitive processing in progressive supranuclear palsy: a comparison with Parkinson’s disease. Archives of Neurology. 1988;45(11):1194–9.CrossRefGoogle ScholarPubMed
Pillon, B, Blin, J, Vidailhet, M, Deweer, B, Sirigu, A, Dubois, B, et al. The neuropsychological pattern of corticobasal degeneration: Comparison with progressive supranuclear palsy and Alzheimer’s disease. Neurology. 1995;45(8):1477–83.CrossRefGoogle ScholarPubMed
Pillon, B, Deweer, B, Michon, A, Malapani, C, Agid, Y, Dubois, B. Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer’s, Parkinson’s, and Huntington’s diseases. Neurology. 1994;44(7):1264.CrossRefGoogle ScholarPubMed
Grafman, J, Litvan, I, Gomez, C, Chase, TN. Frontal lobe function in progressive supranuclear palsy. Archives of Neurology. 1990;47(5):553–8.CrossRefGoogle ScholarPubMed
Dubois, B, Slachevsky, A, Pillon, B, Beato, R, Villalponda, J, Litvan, I. “Applause sign” helps to discriminate PSP from FTD and PD. Neurology. 2005;64(12):2132–3.CrossRefGoogle ScholarPubMed
Vidailhet, M, Rivaud, S, Gouider‐Khouja, N, Pillon, B, Bonnet, AM, Gaymard, B, et al. Eye movements in Parkinsonian syndromes. Annals of Neurology. 1994;35(4):420–6.CrossRefGoogle Scholar
Ghosh, BC, Calder, AJ, Peers, PV, Lawrence, AD, Acosta-Cabronero, J, Pereira, JM, et al. Social cognitive deficits and their neural correlates in progressive supranuclear palsy. Brain: A Journal of Neurology. 2012:aws128.CrossRefGoogle ScholarPubMed
Rippon, G, Boeve, B, Parisi, J, Dickson, D, Ivnik, R, Jack, C, et al. Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer’s disease pathology. Neurocase. 2005;11(3):204–11.CrossRefGoogle Scholar
Karnik, NS, D'Apuzzo, M, Greicius, M. Non-fluent progressive aphasia, depression, and OCD in a woman with progressive supranuclear palsy: neuroanatomical and neuropathological correlations. Neurocase. 2006;12(6):332–8.Google Scholar
Arnulf, I, Merino-Andreu, M, Bloch, F, Konofal, E, Vidailhet, M, Cochen, V, et al. REM sleep behavior disorder and REM sleep without flatonia in patients with progressive supranuclear palsy. Sleep. 2005;28(3):349–54.CrossRefGoogle ScholarPubMed
De Cock, VC, Vidailhet, M, Arnulf, I. Sleep disturbances in patients with parkinsonism. Nature Clinical Practice Neurology. 2008;4(5):254–66.CrossRefGoogle ScholarPubMed
Montplaisir, J, Petit, D, Decary, A, Masson, H, Bédard, M, Panisset, M, et al. Sleep and quantitative EEG in patients with progressive supranuclear palsy. Neurology. 1997;49(4):999–1003.CrossRefGoogle ScholarPubMed
Batla, A, Nehru, R, Vijay, T. Vertical wrinkling of the forehead or Procerus sign in progressive supranuclear palsy. Journal of the Neurological Sciences. 2010;298(1):148–9.CrossRefGoogle ScholarPubMed
Cordato, NJ, Halliday, GM, Caine, D, Morris, JG. Comparison of motor, cognitive, and behavioral features in progressive supranuclear palsy and Parkinson’s disease. Movement Disorders. 2006;21(5):632–8.CrossRefGoogle ScholarPubMed
Romano, S, Colosimo, C. Procerus sign in progressive supranuclear palsy. Neurology. 2001;57(10):1928.CrossRefGoogle ScholarPubMed
Wenning, GK, Geser, F, Krismer, F, Seppi, K, Duerr, S, Boesch, S, et al. The natural history of multiple system atrophy: a prospective European cohort study. The Lancet Neurology. 2013;12(3):264–74.CrossRefGoogle ScholarPubMed
Wenning, G, Shlomo, YB, Magalhaes, M, Danie, S, Quinn, N. Clinical features and natural history of multiple system atrophy. Brain: A Journal of Neurology. 1994;117(4):835–45.CrossRefGoogle ScholarPubMed
Watanabe, H, Saito, Y, Terao, S, Ando, T, Kachi, T, Mukai, E, et al. Progression and prognosis in multiple system atrophy. Brain: A Journal of Neurology. 2002;125(5):1070–83.CrossRefGoogle ScholarPubMed
Schrag, A, Wenning, GK, Quinn, N, Ben‐Shlomo, Y. Survival in multiple system atrophy. Movement Disorders. 2008;23(2):294–6.CrossRefGoogle ScholarPubMed
Gilman, S, Wenning, G, Low, Pa, Brooks, D, Mathias, C, Trojanowski, J, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71(9):670–6.CrossRefGoogle ScholarPubMed
Chang, C, Chang, Y, Chang, W, Lee, Y, Wang, Y, Lui, C, et al. Cognitive deficits in multiple system atrophy correlate with frontal atrophy and disease duration. European Journal of Neurology. 2009;16(10):1144–50.CrossRefGoogle ScholarPubMed
Stankovic, I, Krismer, F, Jesic, A, Antonini, A, Benke, T, Brown, RG, et al. Cognitive impairment in multiple system atrophy: A position statement by the neuropsychology task force of the MDS Multiple System Atrophy (MODIMSA) study group. Movement Disorders. 2014;29(7):857–67.CrossRefGoogle ScholarPubMed
Kim, H-J, Jeon, BS, Kim, YE, Kim, J-Y, Kim, YK, Sohn, C-H, et al. Clinical and imaging characteristics of dementia in multiple system atrophy. Parkinsonism & Related Disorders. 2013;19(6):617–21.CrossRefGoogle ScholarPubMed
Benrud‐Larson, LM, Sandroni, P, Schrag, A, Low, PA. Depressive symptoms and life satisfaction in patients with multiple system atrophy. Movement Disorders. 2005;20(8):951–7.CrossRefGoogle ScholarPubMed
Schrag, A, Sheikh, S, Quinn, NP, Lees, AJ, Selai, C, Mathias, C, et al. A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy. Movement Disorders. 2010;25(8):1077–81.CrossRefGoogle ScholarPubMed
Balas, M, Balash, Y, Giladi, N, Gurevich, T. Cognition in multiple system atrophy: neuropsychological profile and interaction with mood. Journal of Neural Transmission. 2010;117(3):369–75.CrossRefGoogle ScholarPubMed
Fetoni, V, Soliveri, P, Monza, D, Testa, D, Girotti, F. Affective symptoms in multiple system atrophy and Parkinson’s disease: response to levodopa therapy. Journal of Neurology, Neurosurgery & Psychiatry. 1999;66(4):541–4.CrossRefGoogle ScholarPubMed
Kojovic, M, Cordivari, C, Bhatia, K. Myoclonic disorders: a practical approach for diagnosis and treatment. Therapeutic Advances in Neurological Disorders. 2011;4(1):47–62.CrossRefGoogle ScholarPubMed
Wenning, GK, Stefanova, N. Recent developments in multiple system atrophy. Journal of Neurology. 2009;256(11):1791–808.CrossRefGoogle Scholar
Chou, KL, Forman, MS, Trojanowski, JQ, Hurtig, HI, Baltuch, GH. Subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive multiple system atrophy: case report. Journal of Neurosurgery. 2004;100(3):553–6.CrossRefGoogle ScholarPubMed
Shih, LC, Tarsy, D. Deep brain stimulation for the treatment of atypical parkinsonism. Movement Disorders. 2007;22(15):2149–55.CrossRefGoogle ScholarPubMed
Ullman, M, Vedam-Mai, V, Resnick, AS, Yachnis, AT, McFarland, NR, Merritt, S, et al. Deep brain stimulation response in pathologically confirmed cases of multiple system atrophy. Parkinsonism & Related Disorders. 2012;18(1):86–8.CrossRefGoogle ScholarPubMed
Aerts, MB, Esselink, RA, Post, B, van de Warrenburg, BP, Bloem, BR. Improving the diagnostic accuracy in parkinsonism: a three-pronged approach. Practical Neurology. 2012;12(2):77–87.CrossRefGoogle ScholarPubMed
Köllensperger, M, Geser, F, Ndayisaba, JP, Boesch, S, Seppi, K, Ostergaard, K, et al. Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Movement Disorders. 2010;25(15):2604–12.CrossRefGoogle ScholarPubMed
Ghorayeb, I, Bioulac, B, Tison, F. Sleep disorders in multiple system atrophy. Journal of Neural Transmission. 2005;112(12):1669–75.CrossRefGoogle ScholarPubMed
Iranzo, A. Sleep and breathing in multiple-system atrophy. Current Treatment Options in Neurology. 2007;9(5):347–53.CrossRefGoogle ScholarPubMed
Tison, F, Wenning, G, Volonte, M, Poewe, W, Henry, P, Quinn, N. Pain in multiple system atrophy. Journal of Neurology. 1996;243(2):153–6.CrossRefGoogle ScholarPubMed
Boeve, BF, Lang, AE, Litvan, I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Annals of Neurology. 2003;54(S5):S15–9.CrossRefGoogle Scholar
Mathew, R, Bak, TH, Hodges, JR. Diagnostic criteria for corticobasal syndrome: a comparative study. Journal of Neurology, Neurosurgery & Psychiatry. 2011:jnnp-2011–300875.CrossRefGoogle ScholarPubMed
Wenning, G, Litvan, I, Jankovic, J, Granata, R, Mangone, C, McKee, A, et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. Journal of Neurology, Neurosurgery & Psychiatry. 1998;64(2):184–9.CrossRefGoogle ScholarPubMed
Armstrong, MJ, Litvan, I, Lang, AE, Bak, TH, Bhatia, KP, Borroni, B, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80(5):496–503.CrossRefGoogle ScholarPubMed
Lee, SE, Rabinovici, GD, Mayo, MC, Wilson, SM, Seeley, WW, DeArmond, SJ, et al. Clinicopathological correlations in corticobasal degeneration. Annals of Neurology. 2011;70(2):327–40.CrossRefGoogle ScholarPubMed
Boeve, B, Maraganore, D, Parisi, J, Ahlskog, J, Graff-Radford, N, Caselli, R, et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology. 1999;53(4):795.CrossRefGoogle ScholarPubMed
Schneider, J, Watts, R, Gearing, M, Brewer, R, Mirra, S. Corticobasal degeneration. Neuropathologic and clinical heterogeneity. Neurology. 1997;48(4):959–68.CrossRefGoogle Scholar
Alexander, S, Rittman, T, Xuereb, J, Bak, T, Hodges, J, Rowe, J. Validation of the new consensus criteria for the diagnosis of corticobasal degeneration. Journal of Neurology, Neurosurgery & Psychiatry. 2014:jnnp-2013–307035.CrossRefGoogle ScholarPubMed
Massman, PJ, Kreiter, KT, Jankovic, J, Doody, RS. Neuropsychological functioning in cortical-basal ganglionic degeneration. Differentiation from Alzheimer’s disease. Neurology. 1996;46(3):720–6.Google Scholar
Blake, ML, Duffy, J, Boeve, B, Ahlskog, J, Maraganore, D. Speech and language disorders associated with corticobasal degeneration. Journal of Medical Speech–Language Pathology. 2003;11(3):131–46.CrossRefGoogle ScholarPubMed
Rinne, J, Lee, M, Thompson, P, Marsden, C. Corticobasal degeneration: a clinical study of 36 cases. Brain: A Journal of Neurology. 1994;117(5):1183–96.Google Scholar
Cummings, J, Litvan, I. Neuropsychiatric aspects of corticobasal degeneration. In Litvan, I, Goetz, C, Lang, A, editors. Corticobasal Degeneration and Related Disorders. London: Lippincott, Williams & Wilkins; 2000. pp. 147–52.CrossRefGoogle Scholar
Geda, YE, Boeve, BF, Negash, S, Graff-Radford, NR, Knopman, DS, Parisi, JE, et al. Neuropsychiatric features in 36 pathologically confirmed cases of corticobasal degeneration. The Journal of Neuropsychiatry and Clinical Neurosciences. 2006;19(1):77–80.CrossRefGoogle ScholarPubMed
Bruns, MB, Josephs, KA. Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy. International Review of Psychiatry. 2013;25(2):197–209.Google Scholar
Roche, S, Jacquesson, J-M, Destee, A, Defebvre, L, Derambure, P, Monaca, C. Sleep and vigilance in corticobasal degeneration: a descriptive study. Neurophysiologie Clinique/Clinical Neurophysiology. 2007;37(4):261–4.CrossRefGoogle ScholarPubMed
Kompoliti, K, Goetz, C, Boeve, B, Maraganore, D, Ahlskog, J, Marsden, C, et al. Clinical presentation and pharmacological therapy in corticobasal degeneration. Archives of Neurology. 1998;55(7):957–61.CrossRefGoogle ScholarPubMed
Tang-Wai, D, Josephs, K, Boeve, B, Dickson, D, Parisi, J, Petersen, R. Pathologically confirmed corticobasal degeneration presenting with visuospatial dysfunction. Neurology. 2003;61(8):1134–5.Google ScholarPubMed
Leyton, CE, Hodges, JR. Frontotemporal dementias: Recent advances and current controversies. Annals of Indian Academy of Neurology. 2010;13(Supp l2):S74.CrossRefGoogle ScholarPubMed
Rohrer, JD, Warren, JD. Phenotypic signatures of genetic frontotemporal dementia. Current Opinion in Neurology. 2011;24(6):542–9.CrossRefGoogle ScholarPubMed
Siuda, J, Fujioka, S, Wszolek, ZK. Parkinsonian syndrome in familial frontotemporal dementia. Parkinsonism & Related Disorders. 2014;20(9):957–64.CrossRefGoogle ScholarPubMed
Baker, M, Mackenzie, IR, Pickering-Brown, SM, Gass, J, Rademakers, R, Lindholm, C, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442(7105):916–19.CrossRefGoogle Scholar
Gass, J, Cannon, A, Mackenzie, IR, Boeve, B, Baker, M, Adamson, J, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Human Molecular Genetics. 2006;15(20):2988–3001.CrossRefGoogle ScholarPubMed
Boeve, BF, Hutton, M. Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). Archives of Neurology. 2008;65(4):460–4.Google Scholar
Sharon, JS, Takada, LT, Rankin, KP, Yokoyama, JS, Rutherford, NJ, Fong, JC, et al. Frontotemporal dementia due to C9ORF72 mutations. Clinical and imaging features. Neurology. 2012;79(10):1002–11.CrossRefGoogle ScholarPubMed
Rascovsky, K, Hodges, JR, Knopman, D, Mendez, MF, Kramer, JH, Neuhaus, J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain: A Journal of Neurology. 2011;134(9):2456–77.CrossRefGoogle ScholarPubMed
Lindquist, S, Duno, M, Batbayli, M, Puschmann, A, Braendgaard, H, Mardosiene, S, et al. Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease. Clinical Genetics. 2013;83(3):279–83.CrossRefGoogle ScholarPubMed
Ferman, T, McRae, C, Arvanitakis, Z, Tsuboi, Y, Vo, A, Wszolek, Z. Early and pre-symptomatic neuropsychological dysfunction in the PPND family with the N279K tau mutation. Parkinsonism & Related Disorders. 2003;9(5):265–70.CrossRefGoogle ScholarPubMed
Frank, AR, Wszolek, ZK, Jack, CR, Boeve, BF. Distinctive MRI findings in pallidopontonigral degeneration (PPND). Neurology. 2007;68(8):620–1.CrossRefGoogle ScholarPubMed
Geschwind, DH, Robidoux, J, Alarcón, M, Miller, BL, Wilhelmsen, KC, Cummings, JL, et al. Dementia and neurodevelopmental predisposition: cognitive dysfunction in presymptomatic subjects precedes dementia by decades in frontotemporal dementia. Annals of Neurology. 2001;50(6):741–6.CrossRefGoogle ScholarPubMed
Gregory, C, Lough, S, Stone, V, Erzinclioglu, S, Martin, L, Baron‐Cohen, S, et al. Theory of mind in patients with frontal variant frontotemporal dementia and Alzheimer’s disease: theoretical and practical implications. Brain: A Journal of Neurology. 2002;125(4):752–64.CrossRefGoogle Scholar
Seelaar, H, Rohrer, JD, Pijnenburg, YA, Fox, NC, Van Swieten, JC. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. Journal of Neurology, Neurosurgery & Psychiatry. 2010:jnnp. 2010.212225.CrossRefGoogle ScholarPubMed
Torralva, T, Kipps, CM, Hodges, JR, Clark, L, Bekinschtein, T, Roca, M, et al. The relationship between affective decision-making and theory of mind in the frontal variant of fronto-temporal dementia. Neuropsychologia. 2007;45(2):342–9.CrossRefGoogle ScholarPubMed
Hodges, JR. Frontotemporal dementia (Pick’s disease): clinical features and assessment. Neurology. 2001;56(Suppl 4):S6–10.CrossRefGoogle ScholarPubMed
Miller, BL, Boone, K, Cummings, JL, Read, SL, Mishkin, F. Functional correlates of musical and visual ability in frontotemporal dementia. The British Journal of Psychiatry. 2000;176(5):458–63.CrossRefGoogle ScholarPubMed
Miller, BL, Diehl, J, Freedman, M, Kertesz, A, Mendez, M, Rascovsky, K. International approaches to frontotemporal dementia diagnosis: from social cognition to neuropsychology. Annals of Neurology. 2003;54(S5):S7–10.CrossRefGoogle ScholarPubMed
Miller, BL, Seeley, WW, Mychack, P, Rosen, HJ, Mena, I, Boone, K. Neuroanatomy of the self. Evidence from patients with frontotemporal dementia. Neurology. 2001;57(5):817–21.CrossRefGoogle ScholarPubMed
Rankin, KP, Kramer, JH, Mychack, P, Miller, BL. Double dissociation of social functioning in frontotemporal dementia. Neurology. 2003;60(2):266–71.CrossRefGoogle ScholarPubMed
Woolley, J, Gorno-Tempini, M-L, Seeley, W, Rankin, K, Lee, S, Matthews, B, et al. Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia. Neurology. 2007;69(14):1424–33.CrossRefGoogle ScholarPubMed
Benussi, L, Ghidoni, R, Pegoiani, E, Moretti, DV, Zanetti, O, Binetti, G. Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide. Neurobiology of Disease. 2009;33(3):379–85.CrossRefGoogle Scholar
Ranasinghe, K, Pressman, P, Perry, D, Rankin, K, Miller, B. Clinical Characteristics of bvFTD across CDR stages (P3. 201). Neurology. 2014;82(Suppl 10):P3.201–P3.CrossRefGoogle ScholarPubMed
Arvanitakis, Z, Witte, RJ, Dickson, DW, Tsuboi, Y, Uitti, RJ, Slowinski, J, et al. Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation). Parkinsonism & Related Disorders. 2007;13(4):230–9.CrossRefGoogle ScholarPubMed
Boeve, BF, Tremont-Lukats, IW, Waclawik, AJ, Murrell, JR, Hermann, B, Jack, CR, et al. Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation. Brain: A Journal of Neurology. 2005;128(4):752–72.CrossRefGoogle ScholarPubMed
Anderson, K, Hatfield, C, Kipps, C, Hastings, M, Hodges, J. Disrupted sleep and circadian patterns in frontotemporal dementia. European Journal of Neurology. 2009;16(3):317–23.CrossRefGoogle ScholarPubMed
Cipriani, G, Lucetti, C, Danti, S, Nuti, A. Sleep disturbances and dementia. Psychogeriatrics. 2015;15(1):65–74.Google Scholar
Coco, DL, Cupidi, C, Mattaliano, A, Baiamonte, V, Realmuto, S, Cannizzaro, E. REM sleep behavior disorder in a patient with frontotemporal dementia. Neurological Sciences. 2012;33(2):371–3.CrossRefGoogle ScholarPubMed
Boeve, BF, Lin, S-C, Strongosky, A, Dickson, DW, Wszolek, ZK. Absence of rapid eye movement sleep behavior disorder in 11 members of the pallidopontonigral degeneration kindred. Archives of Neurology. 2006;63(2):268–72.Google Scholar
Ahmed, R, Iodice, V, Daveson, N, Kiernan, M, Piguet, O, Hodges, J. Autonomic dysregulation in frontotemporal dementia. Journal of Neurology, Neurosurgery & Psychiatry. 2014:jnnp-2014–309424.CrossRefGoogle ScholarPubMed
Cheshire, WP, Tsuboi, Y, Wszolek, ZK. Physiologic assessment of autonomic dysfunction in pallidopontonigral degeneration with N279K mutation in the tau gene on chromosome 17. Autonomic Neuroscience. 2002;102(1):71–7.CrossRefGoogle ScholarPubMed
Wszolek, Z, Lagerlund, T, Steg, R, McManis, P. Clinical neurophysiologic findings in patients with rapidly progressive familial parkinsonism and dementia with pallido-ponto-nigral degeneration. Electroencephalography and Clinical Neurophysiology. 1998;107(3):213–22.CrossRefGoogle Scholar
Marek, K, Jennings, D, Lasch, S, Siderowf, A, Tanner, C, Simuni, T, et al. The Parkinson progression marker initiative (PPMI). Progress in Neurobiology. 2011;95(4):629–35.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×